Article

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

2021-03-10

Abstract excerpt

The SARS-CoV-2 pandemic virus is consistently evolving with mutations within the receptor binding domain (RBD) 1 being of particular concern 2-4 . To date, there is little research into protection offered following vaccination or infection against RBD mutants in emerging variants of concern (UK 3 , South African 5 , Mink 6 and Southern California 7 ). To investigate this, serum and saliva samples were obtained fro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 47b09574-7a3b-5c35-9dff-9248dc203dab
DOI: 10.1101/2021.03.08.21252958

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immune response to SARS-CoV-2 variants of concern in vaccinated individualsDOI 10.1101/2021.03.08.21252958Read

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.Semantic proximity Read

Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunitySemantic proximity Read

Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workersSemantic proximity Read

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.Semantic proximity Read

SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesSemantic proximity Read

Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infectionSemantic proximity Read

Correlates of protection against SARS-CoV-2 shedding in a controlled human infection study in immune-experienced participantsSemantic proximity Read

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.Semantic proximity Read

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsSemantic proximity Read

Mucosal Immune Response in BNT162b2 COVID-19 Vaccine RecipientsSemantic proximity Read

Reduced neutralization of B.1.351 variant SARS-CoV-2 by convalescent sera of COVID-19 patientsSemantic proximity Read

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationSemantic proximity Read